It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
G protein-independent, arrestin-dependent signaling is a paradigm that broadens the signaling scope of G protein-coupled receptors (GPCRs) beyond G proteins for numerous biological processes. However, arrestin signaling in the collective absence of functional G proteins has never been demonstrated. Here we achieve a state of “zero functional G” at the cellular level using HEK293 cells depleted by CRISPR/Cas9 technology of the Gs/q/12 families of Gα proteins, along with pertussis toxin-mediated inactivation of Gi/o. Together with HEK293 cells lacking β-arrestins (“zero arrestin”), we systematically dissect G protein- from arrestin-driven signaling outcomes for a broad set of GPCRs. We use biochemical, biophysical, label-free whole-cell biosensing and ERK phosphorylation to identify four salient features for all receptors at “zero functional G”: arrestin recruitment and internalization, but—unexpectedly—complete failure to activate ERK and whole-cell responses. These findings change our understanding of how GPCRs function and in particular of how they activate ERK1/2.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany
2 Graduate School of Pharmaceutical Science, Tohoku University, Sendai, Japan; PRESTO, Japan Science and Technology Agency (JST), Kawaguchi, Japan
3 Institute for Molecular Cell Biology, CMB-Center for Molecular Biomedicine, University Hospital Jena, Jena, Germany
4 Bio-Imaging-Center/Rudolf-Virchow-Center, Institute of Pharmacology, University of Wuerzburg, Würzburg, Germany
5 Graduate School of Pharmaceutical Science, Tohoku University, Sendai, Japan
6 Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany
7 Pharmaceutical Biochemistry and Bioanalytics, Institute of Pharmacy, University of Bonn, Bonn, Germany
8 Graduate School of Pharmaceutical Science, Tohoku University, Sendai, Japan; AMED-CREST, Japan Agency for Medical Research and Development, Tokyo, Japan
9 Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, MD, USA